Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| DYNE THERAPEUTICS INC(DYN) | 7,845,364 | 7,845,364 | 0 | 222,730 | 276,863 | 40.83% | +54,133 |
| BICYCLE THERAPEUTICS PLC | 0 | 2,122,892 | +2,122,892 | 0 | 42,967 | 6.34% | +42,967 |
| REPLIMUNE GROUP INC(REPL) | 4,866,449 | 4,866,449 | 0 | 39,759 | 43,798 | 6.46% | +4,039 |
| ACHILLES THERAPEUTICS PLC | 2,390,050 | 2,390,050 | 0 | 2,988 | 1,948 | 0.29% | -1,040 |
| ENGENE HOLDINGS INC *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | 14,966 | 3,425 | 0.51% | -11,541 |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 11,831,461 | 11,831,461 | 0 | 279,814 | 227,282 | 33.52% | -52,532 |
| ENGENE HOLDINGS INC COM | 8,677,951 | 8,677,951 | 0 | 147,091 | 81,833 | 12.07% | -65,258 |